scispace - formally typeset
B

Binhai Zheng

Researcher at University of California, San Diego

Publications -  89
Citations -  13972

Binhai Zheng is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Axon & Myelin. The author has an hindex of 46, co-authored 81 publications receiving 12301 citations. Previous affiliations of Binhai Zheng include University of California, San Francisco & University of Kentucky.

Papers
More filters
Journal ArticleDOI

p63 is a p53 homologue required for limb and epidermal morphogenesis.

TL;DR: P63 is essential for several aspects of ectodermal differentiation during embryogenesis, including hair follicles, teeth and mammary glands, which are absent in p63-deficient mice.
Journal ArticleDOI

Interacting Molecular Loops in the Mammalian Circadian Clock

TL;DR: Analysis of Clock/Clock mutant mice, homozygous Period2(Brdm1) mutants, and Cryptochrome-deficient mice reveals substantially altered Bmal1 rhythms, consistent with a dominant role of PERIOD2 in the positive regulation of the Bmal 1 loop.
Journal ArticleDOI

Nonredundant Roles of the mPer1 and mPer2 Genes in the Mammalian Circadian Clock

TL;DR: The studies show that mPER1 and mPER2 have distinct and complementary roles in the mouse clock mechanism, suggesting independent controls by the two proteins over some output pathways.
Journal ArticleDOI

PTEN deletion enhances the regenerative ability of adult corticospinal neurons

TL;DR: It is found that PTEN/mTOR are critical for controlling the regenerative capacity of mouse corticospinal neurons and modulating neuronal intrinsic PTEN-mTOR activity represents a potential therapeutic strategy for promoting axon regeneration and functional repair after adult spinal cord injury.
Journal ArticleDOI

Reactive astrocyte nomenclature, definitions, and future directions

Carole Escartin, +88 more
- 15 Feb 2021 - 
TL;DR: In this article, the authors point out the shortcomings of binary divisions of reactive astrocytes into good-vs-bad, neurotoxic vs-neuroprotective or A1-vs.A2.